GlassScriptPhysician profile
Sonya L Thomas
NPI 1780698712
$883.27
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.22 · 2020: $247 · 2021: $261 · 2022: $107 · 2023: $145 · 2024: $59.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $366.71 | 2019-2022 | |
| Agile Therapeutics, INC. | $96.86 | 2021-2024 | Twirla |
| Myovant Sciences INC. | $91.74 | 2021-2022 | |
| Hologic Sales and Service, LLC | $51.50 | 2021-2024 | Aptima |
| Avion Pharmaceuticals | $47.53 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $38.50 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $37.60 | 2023 | |
| Boston Scientific Corporation | $33.92 | 2022 | |
| Myriad Women'S Health, INC. | $25.36 | 2023 | Myrisk |
| Organon LLC | $24.73 | 2023 | Nexplanon |
| Astellas Pharma US INC | $21.63 | 2023 | Veozah |
| Allergan, INC. | $18.68 | 2020 | |
| Mylan Pharmaceuticals INC. | $14.61 | 2020 | |
| Therapeuticsmd, INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.